Fisher & Paykel Healthcare has announced new tariffs imposed by the United States on products manufactured outside the US, including a 10% tariff on products made in New Zealand.
The company said it does not anticipate a material impact from the tariffs on its net profit after tax for the 2025 financial year.
However, it expects costs to increase in the 2026 financial year.
Fisher & Paykel Healthcare, which manufactures approximately 45% of its volume in Mexico and 55% in New Zealand, said its manufacturing facilities in both countries have spare capacity to increase volumes if needed.
The company will provide an update on its outlook for the 2026 financial year and the timeframe to return to its gross margin target at its full-year results in May.
See more
